BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caduff N, McHugh D, Rieble L, Forconi CS, Ong'echa JM, Oluoch PO, Raykova A, Murer A, Böni M, Zuppiger L, Schulz TF, Blackbourn DJ, Chijioke O, Moormann AM, Münz C. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection. Cell Rep 2021;35:109056. [PMID: 33951431 DOI: 10.1016/j.celrep.2021.109056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Münz C. Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection. Biomolecules 2022;12:38. [DOI: 10.3390/biom12010038] [Reference Citation Analysis]
2 Münz C. Modification of EBV-Associated Pathologies and Immune Control by Coinfections. Front Oncol 2021;11:756480. [PMID: 34778072 DOI: 10.3389/fonc.2021.756480] [Reference Citation Analysis]
3 Münz C. Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses. Viruses 2021;13:859. [PMID: 34066671 DOI: 10.3390/v13050859] [Reference Citation Analysis]
4 Münz C. Natural Killer Cell Responses during Human γ-Herpesvirus Infections. Vaccines (Basel) 2021;9:655. [PMID: 34203904 DOI: 10.3390/vaccines9060655] [Reference Citation Analysis]
5 Lange PT, White MC, Damania B. Activation and Evasion of Innate Immunity by Gammaherpesviruses. J Mol Biol 2021;:167214. [PMID: 34437888 DOI: 10.1016/j.jmb.2021.167214] [Reference Citation Analysis]
6 Deng Y, Münz C. Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus. Cancers (Basel) 2021;13:2275. [PMID: 34068598 DOI: 10.3390/cancers13092275] [Reference Citation Analysis]